Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $26.1 million.

  • Prokidney's Accumulated Expenses rose 2259.22% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 2259.22%. This contributed to the annual value of $31.1 million for FY2024, which is 7626.38% up from last year.
  • According to the latest figures from Q3 2025, Prokidney's Accumulated Expenses is $26.1 million, which was up 2259.22% from $24.9 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Accumulated Expenses ranged from a high of $31.1 million in Q4 2024 and a low of $5.3 million during Q1 2022
  • Moreover, its 4-year median value for Accumulated Expenses was $15.5 million (2023), whereas its average is $16.4 million.
  • As far as peak fluctuations go, Prokidney's Accumulated Expenses surged by 17548.2% in 2023, and later plummeted by 2786.35% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Accumulated Expenses stood at $7.3 million in 2022, then skyrocketed by 140.8% to $17.7 million in 2023, then surged by 76.26% to $31.1 million in 2024, then fell by 16.28% to $26.1 million in 2025.
  • Its Accumulated Expenses stands at $26.1 million for Q3 2025, versus $24.9 million for Q2 2025 and $27.6 million for Q1 2025.